公开(公告)号：EP4332100A1

公开(公告)日：2024-03-06

申请号：EP22795017.7

申请日：2022-04-29

申请人： Xizang Haisco Pharmaceutical Co., Ltd.

发明人： ZHANG, Chen ,  WANG, Jianmin ,  ZHAO, Chenfei ,  QIAN, Guofei ,  MA, Junjie ,  HUANG, Zhenggang ,  YUAN, Shuai ,  HUANG, Anbang ,  ZHENG, Shaolong ,  LI, Kai ,  YU, Yan ,  YE, Fei ,  TANG, Pingming ,  LI, Yao ,  NI, Jia ,  YAN, Pangke

IPC分类号： C07D401/14 ,  C07F9/53 ,  A61K31/506 ,  A61K31/675 ,  A61P35/00

摘要： Provided are the compound shown in general formula (I) or a stereoisomer, a deuterated compound, a solvate, a prodrug, a metabolite, a pharmaceutically acceptable salt, or co-crystal thereof, an intermediate thereof, and a use thereof in EGFR-related diseases such as cancer. B-L-K (I)